ORAI1 and breast carcinoma: Disruption of Ca2+ signalling by aberrant expression or activity of these two groups of calcium channels is well established in various cancer types [11], such as the role of Orai1 in breast cancer metastasis [13] and T-type Ca2+ channels in breast cancer cell proliferation [19].